Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль

Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0
ClinicalTrialUtilities: обзор

Галерея

BR220737 - SeCore CDx HLA Sequencing System
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-12-01 By FDA
FDA’s Decision to Approve New Treatment for Alzheimer’s Disease
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Aducanumab (marketed as Aduhelm) Information
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
FDA approves drug for adults with rare form of bone marrow disorder
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Verified Clinical Benefit | Infectious Disease Accelerated Approvals (excluding vaccines)
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Verified Clinical Benefit | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Withdrawn | Infectious Disease Accelerated Approvals
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Verified Clinical Benefit | Infectious Disease Accelerated Approvals Vaccines
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Ongoing | Infectious Disease Accelerated Approvals Vaccines
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-12-01 By FDA
Ongoing | Infectious Disease Accelerated Approvals (excluding vaccines)
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Ongoing | Non-malignant Hematology, Neurological Disorders, and Other Indications Accelerated Approvals
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Accelerated Approval Program
Source: FDA - What's New: Drugs RSS Feed Published on 2022-12-01 By FDA
Human medicines European public assessment report (EPAR): Livtencity, maribavir, Cytomegalovirus Infections, Date of authorisation: 09/11/2022, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-12-01
Human medicines European public assessment report (EPAR): Flixabi, infliximab, Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid;Crohn Disease;Psoriasis, Date of authorisation: 26/05/2016, Revision: 22, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-12-01

Предыдущие записи

Тема: Scaffold от Danny Cooper.